BACE2 and diabetes mellitus: Previously, BACE2 has more been reported as the sheddase for pigment cell‐specific melanocyte protein[57] or Tmem27 in β cell,[58] therefore discussed as a potential drug target for melanoma metastasis or diabetes treatment.